Clinical Trials Browser

NIH × Prostatic Neoplasms × Etoposide × Clear all

NCT00627354 2011-05-16

Mitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Phase 2 Completed

Prostatic Neoplasms